Home

Schädlich Mastermind Parade h929 iga kappa Bombe Bach Reisender

plus dead) labeled
plus dead) labeled

Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple  myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry  (MS/MS) | PNAS
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS

Heterogeneity and Plasticity of Multiple Myeloma | IntechOpen
Heterogeneity and Plasticity of Multiple Myeloma | IntechOpen

2-Methoxyestradiol at low dose induces differentiation of myeloma cells
2-Methoxyestradiol at low dose induces differentiation of myeloma cells

NCI-H929细胞ATCC CRL-9068细胞H929人骨髓瘤细胞株购买价格、培养基、培养条件、细胞图片、特征等基本信息_生物风
NCI-H929细胞ATCC CRL-9068细胞H929人骨髓瘤细胞株购买价格、培养基、培养条件、细胞图片、特征等基本信息_生物风

plus dead) labeled
plus dead) labeled

Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines:  Comparison to Normal Lymphocytes, Red Blood Cells and Chron
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron

Establishment and Characterization of a Human Plasma Cell Myeloma Culture  Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect

Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple  myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry  (MS/MS) | PNAS
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS

miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone  Resistance in Multiple Myeloma
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma

Kappa Light Chain Antibody (HP6053 + L1C1) (NBP2-34258): Novus Biologicals
Kappa Light Chain Antibody (HP6053 + L1C1) (NBP2-34258): Novus Biologicals

Establishment of Five Human Myeloma Cell Lines
Establishment of Five Human Myeloma Cell Lines

A novel xenograft mouse model for testing approaches targeting human kappa  light-chain diseases | Gene Therapy
A novel xenograft mouse model for testing approaches targeting human kappa light-chain diseases | Gene Therapy

Goat anti-Human Lambda Light Chain Secondary Antibody (NBP1-72788): Novus  Biologicals
Goat anti-Human Lambda Light Chain Secondary Antibody (NBP1-72788): Novus Biologicals

The Expression and Localization of Kappa Myeloma Antigen on Malignant and  Normal B cells
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells

Establishment of a bortezomib-resistant Chinese human multiple myeloma cell  line: MMLAL
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL

Cell adhesion molecule CD166 drives malignant progression and osteolytic  disease in multiple myeloma
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma

Cdc37 suppression induces plasma cell immaturation and bortezomib  resistance in multiple myeloma via Xbp1s
Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s

Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple  myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry  (MS/MS). - Abstract - Europe PMC
Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). - Abstract - Europe PMC

The Expression and Localization of Kappa Myeloma Antigen on Malignant and  Normal B cells
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells

Cell adhesion molecule CD166 drives malignant progression and osteolytic  disease in multiple myeloma
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma

Upregulated expression and function of the α4β1 integrin in multiple  myeloma cells resistant to bortezomib - Sevilla‐Movilla - 2020 - The  Journal of Pathology - Wiley Online Library
Upregulated expression and function of the α4β1 integrin in multiple myeloma cells resistant to bortezomib - Sevilla‐Movilla - 2020 - The Journal of Pathology - Wiley Online Library

Utility of Intravenous Curcumin Nanodelivery Systems for Improving In Vivo  Pharmacokinetics and Anticancer Pharmacodynamics | Molecular Pharmaceutics
Utility of Intravenous Curcumin Nanodelivery Systems for Improving In Vivo Pharmacokinetics and Anticancer Pharmacodynamics | Molecular Pharmaceutics

WO2015081613A1 - ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B  LYMPHOCYTES AND DECREASING IgA PRODUCTION - Google Patents
WO2015081613A1 - ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION - Google Patents

Response of myeloma to the proteasome inhibitor bortezomib is correlated  with the unfolded protein response regulator XBP-1 | Haematologica
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 | Haematologica